Insider Buying: Gold Standard Ventures Corp (GSV) Director Buys 25,000 Shares of Stock

Share on StockTwits

Gold Standard Ventures Corp (CVE:GSV) Director Jonathan Charles Timothy Awde acquired 25,000 shares of the firm’s stock in a transaction on Friday, April 12th. The stock was bought at an average price of C$1.42 per share, for a total transaction of C$35,550.00. Following the completion of the acquisition, the director now owns 935,194 shares of the company’s stock, valued at C$1,329,845.87.

Gold Standard Ventures Corp has a fifty-two week low of C$1.81 and a fifty-two week high of C$2.14.

COPYRIGHT VIOLATION WARNING: This story was published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.tickerreport.com/banking-finance/4296093/insider-buying-gold-standard-ventures-corp-gsv-director-buys-25000-shares-of-stock.html.

About Gold Standard Ventures

Gold Standard Ventures Corp. is focused on the acquisition and exploration of district-scale and other gold-bearing mineral resource properties completely in the State of Nevada, the United States. The Company operates through the acquisition and exploration of exploration and evaluation assets segment.

Featured Article: Are FAANG stocks a good investment?

Receive News & Ratings for Gold Standard Ventures Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gold Standard Ventures and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Keith Piggott Sells 175,000 Shares of Core Gold Inc  Stock
Keith Piggott Sells 175,000 Shares of Core Gold Inc Stock
Medical Properties Trust, Inc.  Expected to Announce Quarterly Sales of $185.35 Million
Medical Properties Trust, Inc. Expected to Announce Quarterly Sales of $185.35 Million
The Sage Group plc  Given Average Rating of “Hold” by Analysts
The Sage Group plc Given Average Rating of “Hold” by Analysts
BioMarin Pharmaceutical Inc.  Receives $116.25 Average Price Target from Brokerages
BioMarin Pharmaceutical Inc. Receives $116.25 Average Price Target from Brokerages
Linkey Price Reaches $0.60 on Exchanges
Linkey Price Reaches $0.60 on Exchanges
Aeon Market Capitalization Achieves $6.00 Million
Aeon Market Capitalization Achieves $6.00 Million


© 2006-2019 Ticker Report